Skip to main content

Animations

MJFF Publications

3771 - 3780 of 6516 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2019
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2019
  • 2020
  • Summary Details
    OPEN
    Title: Anxiety in Parkinson's disease is associated with changes in the brain fear circuit
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.020
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Robust and facile purification of full-length, untagged human Nedd4 as a recombinant protein from Escherichia coli
    Journal Name: Protein Expression and Purification
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.pep.2020.105649
    Citation Count: 4
  • Summary Details
    OPEN
    Title: A functionalized hydroxydopamine quinone links thiol modification to neuronal cell death
    Journal Name: Redox Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.redox.2019.101377
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic Neurons
    Journal Name: Stem Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.stemcr.2019.12.005
    Citation Count: 61
  • Rebooting Late-Life Mental Health Innovation and Entrepreneurship With Convergence Science
    2020
    Summary Details
    OPEN
    Title: Rebooting Late-Life Mental Health Innovation and Entrepreneurship With Convergence Science
    Journal Name: The American Journal of Geriatric Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jagp.2020.03.003
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Transdifferentiation of Mouse Embryonic Fibroblasts into Dopaminergic Neurons Reactivates LINE-1 Repetitive Elements
    Journal Name: Stem Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.stemcr.2019.12.002
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson's Disease
    Journal Name: The American Journal of Geriatric Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jagp.2020.05.014
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Developing therapies for Parkinson's disease
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30320-3
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Characterization of age-related microstructural changes in locus coeruleus and substantia nigra pars compacta
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.11.016
    Citation Count: 54
  • Summary Details
    OPEN
    Title: Cell death and survival pathways in Alzheimer's disease: an integrative hypothesis testing approach utilizing -omic data sets
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.06.022
    Citation Count: 40
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.